NASDAQ:DCPH
Deciphera Pharmaceuticals Inc Stock News
$25.46
+0.0100 (+0.0393%)
At Close: May 17, 2024
Blueprint's avapritinib pain is Deciphera's gain, up 16%
11:57am, Tuesday, 28'th Apr 2020
Deciphera Pharmaceuticals (NASDAQ:DCPH) is up 16% premarket on light volume on the heels on Blueprint Medicines' plunge after announcing unsuccessful results from late-stage study of avapritinib in�
Blueprint Medicines lead drug flunks GIST study; shares down 15% premarket
11:51am, Tuesday, 28'th Apr 2020
Blueprint Medicines (NASDAQ:BPMC) slumps 15% premarket in reaction to its announcement that a Phase 3 clinical trial, VOYAGER, evaluating lead candidate avapritinib, branded as Ayvakit, in patients
Deciphera Pharmaceuticals, Inc. to Announce First Quarter 2020 Financial Results and Host Conference Call and Webcast on May 5, 2020
11:00am, Tuesday, 28'th Apr 2020
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, today announced that it will report its first q
Covid-19 : comment la dématérialisation dope la résilience de Butagaz
06:00am, Tuesday, 28'th Apr 2020
Des envois postaux
réduits à la portion congrue
, personne dans les bureaux pour ouvrir le courrier et récupérer les factures ou les...
The Best Coffee Makers of 2020 | Digital Trends
09:04pm, Monday, 27'th Apr 2020
Looking for the perfect coffee maker for your favorite brews? From simple to complex, you'll find the most efficient and smartest models available on our list.
Deciphera Pharmaceuticals (NASDAQ:DCPH) Trading 5.6% Higher
07:52am, Sunday, 26'th Apr 2020
Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) traded up 5.6% during mid-day trading on Friday . The stock traded as high as $48.45 and last traded at $48.02, 392,227 shares changed hands during mid-day
Is Deciphera Pharmaceuticals (DCPH) Stock a Solid Choice Right Now?
01:06pm, Thursday, 23'rd Apr 2020
Deciphera Pharmaceuticals (DCPH) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Is Deciphera Pharmaceuticals (DCPH) Stock a Solid Choice Right Now?
01:06pm, Thursday, 23'rd Apr 2020
Deciphera Pharmaceuticals (DCPH) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Michael Douglas Taylor Sells 23,892 Shares of Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) Stock
08:28am, Thursday, 23'rd Apr 2020
Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) Director Michael Douglas Taylor sold 23,892 shares of the business’s stock in a transaction on Friday, April 17th. The shares were sold at an average pric
Is Deciphera Pharmaceuticals a Buy?
11:50am, Wednesday, 22'nd Apr 2020
What should investors think of this late-stage cancer biotech?
Michael Douglas Taylor Sells 1,108 Shares of Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) Stock
10:18am, Saturday, 18'th Apr 2020
Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) Director Michael Douglas Taylor sold 1,108 shares of the business’s stock in a transaction dated Tuesday, April 14th. The shares were sold at an average p
Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) Short Interest Up 17.2% in March
09:32am, Friday, 17'th Apr 2020
Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) was the recipient of a large growth in short interest in the month of March. As of March 31st, there was short interest totalling 3,060,000 shares, a growth